发明名称 Anti-IGF-I receptor antibody
摘要 Antibodies, humanized antibodies, resurfaced antibodies, antibody fragments, derivatized antibodies, and conjugates of same with cytotoxic agents, which specifically bind to, and inhibit, insulin-like growth factor-I receptor, antagonize the effects of IGF-I, IGF-II and serum on the growth and survival of tumor cells, and which are substantially devoid of agonist activity. Said antibodies and fragments thereof may be used in the treatment of tumors that express elevated levels of IGF-I receptor, such as breast cancer, colon cancer, lung cancer, ovarian carcinoma, synovial sarcoma and pancreatic cancer, and said derivatized antibodies may be used in the diagnosis and imaging of tumors that express elevated levels of IGF-I receptor.
申请公布号 US2003235582(A1) 申请公布日期 2003.12.25
申请号 US20020170390 申请日期 2002.06.14
申请人 IMMUNOGEN, INC. 发明人 SINGH RAJEEVA;TAVARES DANIEL J.;DAGDIGIAN NANCY E.
分类号 G01N33/534;A61K39/395;A61P35/00;A61P43/00;C07K16/18;C07K16/28;C07K19/00;C12N1/15;C12N1/19;C12N1/21;C12N5/06;C12N5/10;C12N5/16;C12N15/09;C12N15/13;C12N15/62;C12P21/02;C12P21/08;G01N33/53;(IPC1-7):G01N33/567;G01N33/574;C07K16/26 主分类号 G01N33/534
代理机构 代理人
主权项
地址